| 28th Nov 2024 7:00 am |
RNS |
Expansion of US Commercial Activities |
| 5th Nov 2024 7:00 am |
RNS |
Capital Markets Webinar |
| 4th Nov 2024 7:00 am |
RNS |
Holding(s) in Company |
| 30th Oct 2024 2:58 pm |
RNS |
PDMR Shareholding/Share Incentive Plan |
| 29th Oct 2024 10:27 am |
RNS |
Board Change Update |
| 25th Oct 2024 7:00 am |
RNS |
Issue of Share Options/PDMR Shareholdings |
| 24th Oct 2024 12:53 pm |
RNS |
Cancellation of Share Premium Account |
| 15th Oct 2024 7:00 am |
RNS-R |
Diaceutics Announces Key Leadership Appointment |
| 7th Oct 2024 1:19 pm |
RNS |
Holding(s) in Company |
| 7th Oct 2024 7:00 am |
RNS |
Block Listing Return |
| 2nd Oct 2024 7:00 am |
RNS |
PDMR Shareholding/Share Incentive Plan |
| 1st Oct 2024 7:00 am |
RNS |
Board Changes |
| 17th Sep 2024 7:00 am |
RNS |
H1 2024 Results - Continued Performance & Growth |
| 9th Sep 2024 7:00 am |
RNS |
Notice of Results & Presentations |
| 2nd Sep 2024 7:00 am |
RNS |
Appointment of Nominated Adviser and Broker |
| 30th Aug 2024 3:45 pm |
RNS |
PDMR Shareholding/Share Incentive Plan |
| 27th Aug 2024 7:00 am |
RNS |
Diaceutics Launches Enhanced Rare-Disease Offering |
| 19th Aug 2024 7:00 am |
RNS |
Enterprise Partnership and Launch of PMx |
| 5th Aug 2024 7:00 am |
RNS |
Presenting at Canaccord Genuity Growth Conference |
| 29th Jul 2024 6:09 pm |
RNS |
PDMR Shareholding/SIP and TVR |
| 29th Jul 2024 7:00 am |
RNS |
Issue of Share Options/PDMR Shareholdings |
| 23rd Jul 2024 7:05 am |
RNS |
Board Changes |
| 23rd Jul 2024 7:00 am |
RNS |
Revenue growth of 24% in H1 with 55% now recurring |
| 11th Jul 2024 7:00 am |
RNS |
Senior Management Appointments |
| 1st Jul 2024 7:00 am |
RNS |
PDMR Shareholding/SIP and Total Voting Rights |
| 24th Jun 2024 1:15 pm |
RNS |
Result of AGM |
| 6th Jun 2024 7:00 am |
RNS |
Diaceutics - Capital Markets Event |
| 29th May 2024 8:00 am |
RNS |
Notice of AGM and Posting of Annual Report |
| 28th May 2024 7:00 am |
RNS |
Data to be Presented at 2024 ASCO Annual Meeting |
| 24th May 2024 3:01 pm |
RNS |
PDMR Shareholding/SIP and Total Voting Rights |
| 23rd May 2024 7:00 am |
RNS |
Director / PDMR Shareholding |
| 21st May 2024 7:00 am |
RNS |
Revenue growth of 22% & order book growth of 57% |
| 16th May 2024 7:00 am |
RNS |
Two New Enterprise-Wide Engagements |
| 14th May 2024 7:00 am |
RNS |
Diaceutics - Capital Markets Event |
| 1st May 2024 7:00 am |
RNS |
Notice of Results & Presentations |
| 30th Apr 2024 7:00 am |
RNS |
PDMR Shareholding/SIP and TVR |
| 9th Apr 2024 7:00 am |
RNS |
Appointment of Amie Mc Neice as VP of Marketing |
| 5th Apr 2024 1:40 pm |
RNS |
Block Listing Return |
| 3rd Apr 2024 7:00 am |
RNS |
PDMR Shareholding/Share Incentive Plan |
| 2nd Apr 2024 7:00 am |
RNS |
Director/PDMR/PCA Shareholding & TR1 |
